Science Current Events | Science News | Brightsurf.com
 

Pharmaceuticals Current Events | Pharmaceuticals News | 2

Sort By: Page Views | Date

Antibiotics, antimicrobials and antifungals in waterways
Antibiotics, antimicrobials and antifungals are seeping into the waterways of North America, Europe and East Asia, according to an investigation published in the peer-reviewed journal Environmental Health Perspectives (EHP).   view more (2009-06-10)

Palladium and platinum an easier find with Pitt researcher's detection method
Finding uses for palladium and platinum--rare precious metals coveted by the automobile, chemical, and pharmaceutical industries as catalysts in chemical reactions-proves easier than finding the scarce materials themselves.   view more (2007-09-24)

Triple-Combo Drug Shows Promise Against Antiviral-Resistant Swine Flu, UAB Researcher Says
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.   view more (2009-10-28)

Global Society Launches New Scotland Section - International Science-Business Network Going Coast-to-Coast in Scotland
Thursday 15 June 2000, National Museum of Scotland, Edinburgh, 18:00: A gathering of leading figures from Scottish and international science and business will be present for the launch of the SOCIETY OF CHEMICAL INDUSTRY (SCI) SCOTLAND SECTION. SCI World President Mr Vincent A Calarco, Chairman, President and CEO of CK Witco Corp, USA, will swear... view more... (2000-05-04)

Unusually stable glasses may benefit drugs, coatings
Just spray and chill. That sums up a new approach to making remarkably stable glassy materials from organic (carbon-containing) molecules that could lead to novel coatings and to improvements in drug delivery.   view more (2006-12-11)

Generic biologic drugs unlikely to offer significant savings
Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.   view more (2007-05-02)

Xerion Pharmaceuticals and Arius Research sign colon cancer collaboration
Martinsried, Germany and Cambridge, Massachusetts, USA - October 15, 2002"¦Xerion Pharmaceuticals and ARIUS Research Inc. of Canada announced today that they would combine their respective strengths in functional proteomics and antibody discovery to jointly develop products for cancer therapy. Xerion will take four antibodies from ARIUS'... view more... (2002-10-15)

Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.   view more (2009-03-27)

Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.   view more (2009-03-26)

BC catalyst discovery promises faster, cheaper drug production
Boston College chemists have discovered a substance that will make it possible for scientists to produce scores of pharmaceuticals and other chemicals in a faster, less expensive way.   view more (2006-09-07)

Oxford BioMedica plc appoints David Higgins as Vice President, Business Development
Oxford, United Kingdom and San Diego, USA - 14 November 2002... Oxford BioMedica plc announced today the appointment of Dr. David Higgins as Vice President for Business Development. He has been appointed to Oxford BioMedica's San Diego subsidiary to spearhead business development primarily in the USA. Dr. Higgins has extensive experience in the... view more... (2002-11-14)

Royal Society welcomes Government report on crops of the future
The potential benefits of NFCs, and the myriad of uses to which they could be put, were explored in the Society's submission to the Select Committee, the main points of which were:   view more (1999-12-17)

Chemistry & Industry Issue 2 - Cover Date Monday 21 January 2002
NEWS   view more (2002-01-16)

New compound effectively treats fungal infections
A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory [EMBL] outstation in Grenoble, France.   view more (2007-06-25)

Studying the fate of drugs in wastewater
Researchers at the National Institute of Standards and Technology (NIST) have published an interesting study that sheds light on the fate of a familiar pharmaceutical as it enters the waste stream.   view more (2005-12-27)

Distinguished Service Award presented by science society
9 July 2003, London, UK: Mrs Rosemary Wood, Society of Chemical Industry (SCI) will be presented with the Distinguished Service Award at the 122nd Annual Meeting today at SCI international headquarters, London, UK. Mrs Wood contributed 21 years of service to SCI starting in 1981. The first half was spent as Personal Assistant to the General... view more... (2003-07-08)

POLYMUN Scientific to present at the 4X4 pour entrepreneur
POLYMUN Scientific, together with 20 other companies, has been selected from 300 submissions to present its innovative pharmaceutical projects at the prestigious "Taste of Entrepreneurship: Financing and Research" symposium in Louvain-La-Neuve, Belgium, Nov. 19 and 20, 2002. POLYMUN will present its pharmaceutical projects in view of the newest... view more... (2002-11-15)

Advances in lung cancer research announced at conference
Dr. Glen Weiss of the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare this week announced two significant advances in treating lung cancer at an international cancer research conference.    view more (2009-08-10)

Founder's Lecture will Recognise the Success of Colloid Chemist
Professor Terence Cosgrove, University of Bristol, UK, will deliver the Founder's Lecture 'Chains and Bondage' at the Society of Chemical Industry (SCI) Headquarters, London on 21 April 2004. The Founder's Lecture is awarded to figures of distinction in the colloid or surface chemistry fields. A Professor of Physical Chemistry, Terence Cosgrove is... view more... (2004-04-19)

Patch to Help Cut Down Alcohol Consumption in Development
A patch that could help drinkers cut down on alcohol is being developed, reports Marina Murphy in Chemistry & Industry Magazine. The patches will contain nicotine, to help smokers get off cigarettes, and a compound called mecamylamine, which reduces a person's desire to both drink and smoke. Mecamylamine works by modulating the activity of... view more... (2004-04-15)
Sort By: Page Views | Date
© 2009 BrightSurf.com